In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Drug:  tositumomab and iodine I 131 tositumomab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: COULTER-RIT-11-004, NCI-V97-1245

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068321, U10CA032102, S0016, CALGB-50102, SWOG-S0016, ECOG-SWOG-S0016, NCT00006721

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI, NHLBI
Protocol IDs: 384, BMT CTN 0401, U01 HL069294-05, FHCRC-2125.00, NCT00329030

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 14 to 70
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CWRU-CELL-1497, CP-0154-010, NCI-G98-1430

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066917, S9911, U10CA032102, SWOG-9911, NCT00003784

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 59
Sponsor: NCI, Other
Protocol IDs: 1368.00, NCI-2009-01469, P01CA044991, FHCRC-1368.00, NCT00073918

7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP-99-032, NCT00022932

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP-99-037, NCT00022945

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000415955, S0433, U10CA032102, SWOG-S0433, NCT00107380

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2005.035, IRB # 2005-0403 and HUM 43767, NCT00135200

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 393229/032, NCT00240565

12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PSOC 2301, NCI-2011-01311, NCT00476047

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: LYM 2005-01, NCT00479167

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LYMNHL0019, 10275, NCT00490009

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: LYMNHL0046, 97437, 7479, NCT00490490

16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 60 to 80
Sponsor: NCI, Other
Protocol IDs: 1366.00, CDR0000341125, FHCRC-1366.00, NCT00073931

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 19 to 70
Sponsor: Other
Protocol IDs: 051-00, UNMC-051-00, COULTER-IND-3323, NCT00006695

18.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 1943.00, NCI-2009-01470, P01CA044991, FHCRC-1943.00, NCT00110071

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 100
Sponsor: NCI, Other
Protocol IDs: JHOC-J0636, CDR0000522705, NCT00416312
New Search